NK:IO, a leader in NK cell biology applied to the development of exceptionally potent, off-the-shelf cell therapies targeting solid tumors, today announced it has been awarded £1.6M in grant funding from Innovate UK’s New Cancer Therapeutics program.
Senate bill would permanently extend Covid-era rules on telehealth addiction treatment
A bipartisan group of senators this week introduced a bill that would permanently allow health providers to prescribe buprenorphine, a common medication used to treat